CA2514636C - Adhesive material and adhesive preparation - Google Patents
Adhesive material and adhesive preparation Download PDFInfo
- Publication number
- CA2514636C CA2514636C CA2514636A CA2514636A CA2514636C CA 2514636 C CA2514636 C CA 2514636C CA 2514636 A CA2514636 A CA 2514636A CA 2514636 A CA2514636 A CA 2514636A CA 2514636 C CA2514636 C CA 2514636C
- Authority
- CA
- Canada
- Prior art keywords
- synthetic rubber
- adhesive
- adhesive material
- adhesive layer
- kinds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
- A61F13/0253—Adhesive plasters or dressings characterised by the skin adhering layer characterized by the adhesive material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0246—Adhesive plasters or dressings characterised by the skin adhering layer
- A61F13/0256—Adhesive plasters or dressings characterised by the skin adhering layer characterized by the parametric properties of the adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
Abstract
The present invention provides an adhesive material to be adhered to the skin etc., which maintains, for a certain time period after adhesion thereof to the skin surface, suitable adhesiveness that does not allow easy peeling or cause irritation to the skin, and which permits, when it is to be peeled off from the skin surface after the lapse of a desired certain time period, easy peeling without causing pain or physical irritation, and an adhesive preparation containing the adhesive material and a percutaneously absorbable drug in the adhesive layer. Specifically, the present invention provides an adhesive material containing a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 30°C of 0.2×10 4 to 10×10 4Pa.cndot.s and comprises two kinds of synthetic rubbers having different flowability.
Description
SPECIFICATION
ADHESIVE MATERIAL AND ADHESIVE PREPARATION
FIELD OF THE INVENTION
The present invention relates to an adhesive material for adhesion to the skin surface, which comprises an adhesive layer laminated on one surface of a support, which has suitable adhesiveness while it is adhered and which can be peeled off easily when it is detached, and an adhesive preparation comprising a percutaneously absorbable drug in an adhesive layer of the adhesive material.
BACKGROUND OF THE INVENTION
In recent years, various adhesion-type percutaneously absorbable preparations for continuous administration of a drug from the skin surface have been developed and become commercially available. The technical direction they pursue from now on will be toward maintenance of superior drug absorbability while suppressing skin irritation that occurs upon adhesion and peeling off of the preparation.
However, too much emphasis on the suppression of physical stimulation upon peeling off, which leads to unnecessarily reduction of the adhesive force, undesirably impairs adhesiveness of adhesive preparation. Particularly, in the case of a percutaneously absorbable adhesive preparation containing a drug, falling off of the preparation during the effective period becomes a serious defect that loses effectiveness as a pharmaceutical product.
To suppress physical irritation upon peeling off, for example, a method ensuring an adequate adhesive force and suppressing damages on the keratin layer upon peeling off of adhesive preparation by constituting a special gel structure (JP-B-2700835, JP-B-2970772), a method using a highly permeable support and a special adhesive (JP-B-2524190), a method using an adhesive layer designed to be re-adherable, wherein the adhesion site is changed during the effective period (US Patent No. 6348210) and the like have been disclosed. However, none has ever existed which takes note of changing the peelability between the initial stage of adhesion and at the time of peeling off, thereby to maintain fine drug absorbability and suppress skin irritation caused by adhesion and peeling off.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide an adhesive material for adhesion to the skin surface, which has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, and that allows easy peeling off from the skin surface without a pain or physical irritation after a certain, desired time period, and an adhesive preparation comprising a percutaneously absorbable drug in the adhesive material.
The present inventors have conducted intensive studies in an attempt to solve the above-mentioned problems and took note of changing the peelability of an adhesive material, which comprises an adhesive layer laminated on one surface of a support, between the initial stage of adhesion and at the time of peeling off. They have further investigated and found that an adhesive layer having an apparent viscosity at 30 C of 0.2x104-lOXlO4Pa=s and comprising two kinds of synthetic rubbers having different flowability can solve the above-mentioned problem, which resulted in the completion of the present invention.
Accordingly, the present invention provides the following.
(1) An adhesive material comprising a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 30 C of 0.2X104 to 1OX104Pa=s and comprises two kinds of synthetic rubbers having different flowability.
(2) The adhesive material of the above-mentioned (1), wherein the above-mentioned adhesive layer may further comprise a tackifier.
ADHESIVE MATERIAL AND ADHESIVE PREPARATION
FIELD OF THE INVENTION
The present invention relates to an adhesive material for adhesion to the skin surface, which comprises an adhesive layer laminated on one surface of a support, which has suitable adhesiveness while it is adhered and which can be peeled off easily when it is detached, and an adhesive preparation comprising a percutaneously absorbable drug in an adhesive layer of the adhesive material.
BACKGROUND OF THE INVENTION
In recent years, various adhesion-type percutaneously absorbable preparations for continuous administration of a drug from the skin surface have been developed and become commercially available. The technical direction they pursue from now on will be toward maintenance of superior drug absorbability while suppressing skin irritation that occurs upon adhesion and peeling off of the preparation.
However, too much emphasis on the suppression of physical stimulation upon peeling off, which leads to unnecessarily reduction of the adhesive force, undesirably impairs adhesiveness of adhesive preparation. Particularly, in the case of a percutaneously absorbable adhesive preparation containing a drug, falling off of the preparation during the effective period becomes a serious defect that loses effectiveness as a pharmaceutical product.
To suppress physical irritation upon peeling off, for example, a method ensuring an adequate adhesive force and suppressing damages on the keratin layer upon peeling off of adhesive preparation by constituting a special gel structure (JP-B-2700835, JP-B-2970772), a method using a highly permeable support and a special adhesive (JP-B-2524190), a method using an adhesive layer designed to be re-adherable, wherein the adhesion site is changed during the effective period (US Patent No. 6348210) and the like have been disclosed. However, none has ever existed which takes note of changing the peelability between the initial stage of adhesion and at the time of peeling off, thereby to maintain fine drug absorbability and suppress skin irritation caused by adhesion and peeling off.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide an adhesive material for adhesion to the skin surface, which has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, and that allows easy peeling off from the skin surface without a pain or physical irritation after a certain, desired time period, and an adhesive preparation comprising a percutaneously absorbable drug in the adhesive material.
The present inventors have conducted intensive studies in an attempt to solve the above-mentioned problems and took note of changing the peelability of an adhesive material, which comprises an adhesive layer laminated on one surface of a support, between the initial stage of adhesion and at the time of peeling off. They have further investigated and found that an adhesive layer having an apparent viscosity at 30 C of 0.2x104-lOXlO4Pa=s and comprising two kinds of synthetic rubbers having different flowability can solve the above-mentioned problem, which resulted in the completion of the present invention.
Accordingly, the present invention provides the following.
(1) An adhesive material comprising a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 30 C of 0.2X104 to 1OX104Pa=s and comprises two kinds of synthetic rubbers having different flowability.
(2) The adhesive material of the above-mentioned (1), wherein the above-mentioned adhesive layer may further comprise a tackifier.
(3) The adhesive material of the above-mentioned (2), wherein the above-mentioned adhesive layer further comprises an organic liquid compatible with the above-mentioned two kinds of synthetic rubbers and the tackifier.
(4) The adhesive material of the above-mentioned (3), wherein the organic liquid is contained in a proportion of not more than 20% of the total weight of the above-mentioned adhesive layer.
(5) The adhesive material of the above-mentioned (1) or (2), wherein the two kinds of synthetic rubbers comprise a first synthetic rubber, which is a branched aliphatic hydrocarbon having a Staudinger Index of 170-300 cm3/g, and a second synthetic rubber, which is a branched aliphatic hydrocarbon having a Staudinger Index of 30-60 cm3/g.
(6) The adhesive material of the above-mentioned (5), wherein the branched aliphatic hydrocarbon is a 2-methylpropene polymer.
(7) The adhesive material of the above-mentioned (2), wherein the tackifier is an ethylethylene polymer, a 1,2-dimethylethylene polymer or an ethylethylene-1,2-dimethylethylene copolymer having a kinematic viscosity at 40 C
of 200-4000 mm2/s.
of 200-4000 mm2/s.
(8) The adhesive material of the above-mentioned (2), wherein the tackifier is an alicyclic saturated hydrocarbon resin having a softening point of 70-125 C.
(9) The adhesive material of the above-mentioned (2), wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a second synthetic rubber having a lower Staudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:12-20:7-11 by weight.
(10) The adhesive material of the above-mentioned (2), wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a ,second synthetic rubber having a lower Staudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:12-20:2-6 by weight.
(11) The adhesive material of the above-mentioned (2), wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a second synthetic rubber having a lower Saudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:25-45:0-2 by weight.
(12) The adhesive material of the above-mentioned (3) or (4), wherein the organic liquid is at least one member selected from isopropyl myristate and a branched long-chain alcohol.
(13) The adhesive material of the above-mentioned (12), wherein the branched long-chain alcohol is at least one member selected from isostearyl alcohol and octyldodecanol.
(14) The adhesive material of the above-mentioned (12) or (13), wherein the organic liquid is isopropyl myristate, the organic liquid optionally further comprises a branched long-chain alcohol, and a mixing ratio of isopropyl myristate:branched long-chain alcohol is 1:0-4 by weight.
(15) An adhesive preparation comprising a percutaneously absorbable drug in the adhesive layer of the adhesive material of above-mentioned (1)-(14).
According to another aspect of the present invention, there is provided an adhesive material comprising a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 300C
of 0.2x104 to 10x104Pa=s and comprises two kinds of synthetic rubbers having different flowability, wherein the synthetic rubber is a branched aliphatic hydrocarbon, and the proportion of the two kinds of synthetic rubbers relative to the total weight of the adhesive layer is 50-100%.
EFFECT OF THE INVENTION
The adhesive material of the present invention has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, and that allows easy peeling off from the skin surface without a pain or physical irritation after a certain, desired time period.
4a The adhesive preparation of the present invention has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, can maintain fine absorbability of a percutaneously absorbable drug, which is an active ingredient, and can be easily peeled off from the skin surface without a pain or physical irritation after a certain, desired time period. Particularly, the adhesive material of the present invention can be easily peeled off after a desired period of 1 to 3 days by changing the mixing ratio of two kinds of synthetic rubbers having different flowability and tackifier to be added to the adhesive layer. Similarly, the adhesive preparation of the present invention is useful in that it can be peeled off easily after a desired period of 1 to 3 days according to the kind of the drug therein, which is an active ingredient.
In addition, an adhesive preparation obtained by adding 5% isosorbide dinitrate (ISDN) to the adhesive material of the present invention (Example 3 below) was subjected to an in vitro permeability test using a skin removed from a mouse, and the percutaneous absorbability of ISDN was confirmed. Thus, the adhesive preparation of the present invention is useful as a percutaneously absorbable adhesive preparation for continuous administration of a drug into the body.
BEST MODE FOR CARRYING OUT THE INVENTION
The adhesive material of the present invention is characterized in that an adhesive layer is laminated on one surface of a support, and the adhesive layer contains two kinds of synthetic rubbers having different flowability and has an apparent viscosity at 30 C of 0.2x104-10x104Pa=s.
Due to the above-mentioned constitution, the adhesive material has sufficient adhesiveness that does not allow easy peeling off at least in the initial stage of adhesion, maintains suitable adhesiveness, and permits peeling off with a force free of a pain or physical irritation after use.
While the support of the present invention is not particularly limited, those substantially impermeable to drug and the like, namely, those free of a decrease in the content due to the loss of a percutaneously absorbable drug, additives and the like from the adhesive layer through a support are preferable. As the support, for example, single films of polyester, nylon, saran (registered trademark), polyethylene, polypropylene, polyvinyl chloride, ethylene-ethyl acrylate copolymer, polytetrafluoroethylene, Surlyn (registered trademark), metal foil and the like, lamination films of these and the like can be used. Of these, the support is preferably a lamination film of a non-porous plastic film made from the above-mentioned material and a porous film, so as to improve the adhesive force (anchor property) between the support and an adhesive layer. In this case, the adhesive layer is preferably formed on the porous film side.
As such porous film, one capable of improving the anchor property with the adhesive layer can be employed.
Specifically, paper, woven fabric, non-woven fabric, knitted fabric, mechanically perforated sheet and the like can be mentioned. Of these, from the aspects of handling property and the like, paper, woven fabric and non-woven fabric are particularly preferable. A porous film having a thickness of 10-200 pm is employed from the aspects of improved anchor property, flexibility of adhesive material and adhesive preparation as a whole, and adhesion operability and the like.
In the case of a thin preparation such as a plaster type preparation and a pressure-sensitive adhesive tape type preparation, one having a thickness of 10-100 m is employed.
When a woven fabric or a non-woven fabric is used as the porous film, the fabric weight is preferably set to 5-30 g/m2, more preferably 6-15 g/m2. In the present invention, the most preferable support is a lamination film of a polyester film (preferably polyethylene terephthalate film) having a thickness of 1.5-6 pm and a non-woven polyester (preferably polyethylene terephthalate) fabric having a fabric weight of 6-12 g/m2.
The adhesive layer in the present invention comprises two kinds of synthetic rubbers having different flowability.
In the present invention, "having different flowability"
means difference in viscoelasticity due to different molecular weights and crosslinking densities, and the difference appears in, for example, glass transition temperature and kinematic viscosity. In general, the flowability can be expressed by a Staudinger-Index and the like.
In the present invention, the Staudinger-Index is measured according to ASTM D445, IS03104.
In the present specification, one of the two kinds of synthetic rubbers having different flowability is also referred to as the first synthetic rubber, and the other synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber is also referred to as the second synthetic rubber.
The apparent viscosity at 30 C of the adhesive layer in the present invention is 0.2x104 to 1Ox104Pa-s, preferably 0.5x104 to 9.5x104Pa-s. When the apparent viscosity at 30 C is less than 0.2x104Pa-s, cohesive failure markedly occurs irrespective of the duration of adhesion, and when it exceeds 1Ox104Pa-s, the adhesive force becomes insufficient and adhesiveness becomes poor.
The apparent viscosity in the present invention is obtained by measurement the following conditions according to JIS K7210 and using a flow tester CFT-500C (manufactured by Shimadzu Corporation), and calculation by the following calculation formulas.
[Measurement conditions]
Cylinder pressure: 30.0 kgf/cm2 Die used: L: 10.00 mm, D: 1.00 mm Preheating time: 300s Apparent shear stress: 7.36x105 dyn/cm2 Measurement start position S1: 3 mm Measurement end position S2: 7 mm Q=A = S2_S1 (cm3/s) 1 0 A t y= 1 03 (s-1) iD3 PD
(P a) T 7rD4P
n = X 1 0-3 (P a s) y 1 2 8 L Q
wherein each symbol shows the following:
Q: flow rate y: apparent shear velocity T: apparent shear stress ,n: apparent viscosity A: piston cross-section area (cm2) S1: measurement start position (mm) S2: measurement end position (mm) At: lapse of time for a piston to reach measurement end position from the measurement start position D: die bore diameter (mm) P: test pressure (Pa) L : die length (mm) As the synthetic rubber to be used in the present invention, for example, polydimethyl siloxane resin, butyl rubber, ethylene-vinylacetate copolymer, ethylene-ethylacrylate copolymer, polyalkylvinylether (e.g., polypropylvinylether, polyisopropylvinylether, polybutylvinylether etc.), 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, ethylethylene-1,2-dimethylethylene copolymer, polyisoprene, polybutadiene and the like can be mentioned, with preference given to 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, and ethylethylene-1,2-dimethylethylene copolymer, from the aspects of cost, handleability and the like.
As the synthetic rubber to be used in the present invention, a branched aliphatic hydrocarbon is particularly preferable. As the branched aliphatic hydrocarbon, for example, polymers and copolymers obtained from monomers such as 2-methylpropene, ethylethylene, 1,2-dimethylethylene and the like can be mentioned. Specifically, 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, ethylethylene-l,2-dimethylethylene copolymer and the like can be mentioned.
In the present invention, two kinds of synthetic rubbers having different flowability are not particularly limited, but the first synthetic rubber is preferably a branched aliphatic hydrocarbon having a Staudinger-Index of 170-300 cm3/g, preferably 180-290 cm3/g, and the second synthetic rubber is preferably a branched aliphatic hydrocarbon having a Staudinger-Index of 30-60 cm3/g, preferably 35-55 cm3/g. In this case, when the Staudinger-Index of the first synthetic rubber is less than 170 cm3/g, the cohesion tends to become insufficient and when it exceeds 300 cm3/g, the tack of an adhesive tends to become low. When the Staudinger-Index of the second synthetic rubber is less than 30 cm3/g, the adhesive shows greater stickiness, which sometimes exerts an adverse influence on peeling in a desired number of days, and when it exceeds 60 cm3/g, the apparent viscosity of an adhesive becomes higher than the predetermined range, which may in turn result in a failure to adhere for the desired number of days.
As the branched aliphatic hydrocarbon when the first synthetic rubber is "a branched aliphatic hydrocarbon having a Staudinger-Index of 170-300 cm3/g (preferably 180-290 cm3/g)", 2-methylpropene polymer is preferable.
As the branched aliphatic hydrocarbon when the second synthetic rubber is "a branched aliphatic hydrocarbon having a Staudinger-Index of 30-60 cm3/g (preferably 35-55 cm3/g)", 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer and ethylethylene-1,2-dimethylethylene copolymer are preferable.
The proportion of the two kinds of synthetic rubbers having different flowability relative to the total weight of the adhesive layer is preferably 50-100%, more preferably 60-100%, in the total weight. The proportion of the first synthetic rubber of the two kinds of synthetic rubbers having different flowability relative to the whole weight of the adhesive layer is preferably 10-45%, more preferably 15-40%.
The proportion of the second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber, relative to the whole weight of the adhesive layer is preferably 30-85%, more preferably 35-80%. When the adhesive layer contains a drug, the above-mentioned proportion does not include the amount of the drug.
The adhesive layer in the present invention may further contain a tackifier. By the addition of a tackifier, the adhesion period from the start of the adhesion to the skin surface until the layer comes to have peelability permitting easy peeling off can be extended. In addition, by setting the mixing ratio of the two kinds of synthetic rubbers having different flowability and a tackifier to the one exemplified below, an adhesive preparation for a desired period of adhesion suitable for the kind of the drug can be prepared.
The tackifier to be used for the present invention may be appropriately selected from those known in the field of adhesive preparations. As the tackifier, for example, polybutenes, rosin resin, terpene resin, petroleum resin, chroman resin and the like can be mentioned. From the aspect of compatibility, (i) ethylethylene polymer, 1,2-dimethylethylene polymer and ethylethylene-l,2-dimethylethylene copolymer, each having a kinematic viscosity at 40 C of 200-4000 mm 2/s, preferably 500-700 mm2/s; and (ii) an alicyclic saturated hydrocarbon resin having a softening point of 70-125 C, preferably 90-115 C, are preferable. When the kinematic viscosity of the above-mentioned (i) is less than 200 mm2/s, the skin surface may become sticky after peeling off or the adhesive may bleed, and when it exceeds 4000 mm 2/s, a desired tack may not be obtained.
When the softening point of the above-mentioned (ii) is less than 70 C, the skin surface may become sticky after peeling off, the adhesive may bleed, or thermal stability may be degraded, and when it exceeds 125 C, compatibility may be degraded.
As the alicyclic saturated hydrocarbon resin having a softening point of 70-125 C, preferably 90-115 C, for example, a thermoplastic hydrogenation resin having an alicyclic structure formed by adding hydrogen to hydrocarbon resin obtained by polymerization of aromatic hydrocarbon (C9-C12) containing styrene, a-methylstyrene, vinyltoluene, indene, methylindene and the like, and the like can be mentioned.
The tackifier may be used in a combination of one or more kinds thereof.
The kinematic viscosity in the present invention is measured according to JIS K2283 and IS03104.
The softening point in the present invention is measured according to pharmaceutical product additive standard (109992).
The proportion of the tackifier relative to the total weight of the adhesive layer is preferably 0-40%, more preferably 0-30%, in the total weight. When a drug is contained, however, the above-mentioned proportion does not include the weight of the drug.
The adhesive layer in the present invention may further contain an organic liquid compatible with the above-mentioned two kinds of synthetic rubbers having different flowability, and the above-mentioned tackifier.
The organic liquid to be used in the present invention is not particularly limited as long as it is compatible with the above-mentioned two kinds of synthetic rubbers having different flowability, and the above-mentioned tackifier, and as long as it does not lose adhesive property. When an adhesive preparation containing a drug is produced, however, the organic liquid preferably dissolves the drug, and has an absorption promoting action to improve percutaneous absorbability of the contained drug. As the organic liquid, for example, higher alcohols such as oleyl alcohol, isostearyl alcohol, octyldodecanol and the like, oils and fats such as olive oil, castor oil, squalene, lanolin and the like, organic solvents such as ethyl acetate, ethyl alcohol, dimethyldecylsulfoxide, methyloctylsulfoxide, dimethylsulfoxide, dimethylformamide, dimethylacetamide, dodecylpyrrolidone, isosorbitol and the like, plasticizer liquid surfactants such as phthalate, diethyl sebacate, triethyl citriate, tributyl acetyl citrate and the like, liquid paraffin and the like hydrocarbons, ethoxylated stearyl alcohol, glycerine fatty acid ester, isopropyl myristate, isotridecyl myristate, ethyl laurate, N-methylpyrrolidone, ethyl oleate, oleic acid, diisopropyl adipate, isopropyl palmitate, 1,3-butanediol and the like can be mentioned. These organic liquids may be used in combination of one or more kinds thereof.
Of these organic liquids, preferred are fatty acid ester and glycerine fatty acid ester (particularly fatty acid monoglyceride). While these fatty acid esters and glycerine fatty acid esters are preferable as long as they plasticize an adhesive, a fatty acid having an unnecessarily large or small number of carbons may degrade compatibility with the aforementioned synthetic rubber and the like, or may be volatilized in a heating step for producing a preparation. In addition, an organic liquid made of a fatty acid having a double bond in a molecule may give rise to a problem in the preservation stability due to oxidative degradation and the like. Moreover, when an adhesive preparation is produced, a high content of a percutaneously absorbable drug per unit area leads to the precipitation of the drug above the saturation solubility in the preparation. Depending on the kind of fatty acid ester and glycerine fatty acid ester to be added, the crystal precipitation of the drug may be inhibited or precipitation may be delayed, which in turn may degrade the appearance of the obtained preparation or may adversely affect the preservation stability.
As the fatty acid ester to be used, therefore, a fatty acid ester comprising a higher fatty acid preferably having 12 to 16, more preferably 12-14, carbon atoms and a lower monovalent alcohol having 1 to 4 carbon atoms is employed. As such higher fatty acid, preferred are lauric acid (C12), myristic acid (C14) and palmitic acid (C16), and myristic acid is particularly preferable. As the lower monovalent alcohol, methyl alcohol, ethyl alcohol, propyl alcohol and butyl alcohol can be mentioned, which may be a straight chain alcohol or a branched alcohol. Desirably, isopropyl alcohol is used. Therefore, most preferable fatty acid ester is isopropyl myristate.
As the glycerine fatty acid ester, glyceride with higher fatty acid having 8 to 10 carbon atoms is preferable. As such higher fatty acid, preferred are caprylic acid (octanoic acid, C8), pelargonic acid (nonanoic acid, C9) and capric acid (decanoic acid, C10), and particularly preferred are caprylic monoglyceride, caprylic diglyceride, caprylic triglyceride and caprilyc capric triglyceride using caprylic acid.
When a higher alcohol is used as an organic liquid, for example, a saturated or unsaturated branched long-chain alcohol having 16 to 22, preferably 18-20, carbon atoms, such as isostearyl alcohol, octyldodecanol and the like are more preferable.
An embodiment wherein the organic liquid is isopropyl myristate and a branched long-chain alcohol is optionally contained as an organic liquid is particularly preferable. In this case, the mixing ratio of isopropyl myristate and a branched long-chain alcohol is preferably 1:0-4, more preferably 1:0-3, by weight.
When the mixing ratio of the branched long-chain alcohol relative to isopropyl myristate exceeds 4 by weight, the adhesiveness during perspiration may become lower and the preparation may come off during application.
The proportion of the organic liquid relative to the total weight of the adhesive layer is preferably not more than 20% in the total weight, so as to maintain special adhesive property of the present invention.
The adhesive layer may contain, as optional components, other additives (e.g., polymers such as polyvinylpyrrolidone, aminoalkyl methacrylate copolymer, methacrylic acid copolymer and the like, esters such as sorbitan fatty acid ester, propyleneglycol fatty acid ester and the like, inorganic compounds such as magnesium aluminum silicate and the like, other inorganic or organic fillers etc.), as long as the effect of the present invention is not inhibited. The proportion of other additives as optional components is preferably not more than 15% of the total weight of the adhesive layer.
In the present invention, by setting a particular mixing ratio of two kinds of synthetic rubbers having different flowability and a tackifier, an adhesive material permitting easy peeling off in a desired period of 1 to 3 days can be prepared. Particularly, the adhesive preparation of the present invention is useful because it can be easily peeled off in a desired period of 1 to 3 days according to the kind of the drug, which is an active ingredient.
For 3 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:12-20:7-11, by weight.
For 2 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:12-20:2-6, by weight.
For 1 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:25-45:0-2, by weight.
The thickness of the adhesive layer is generally 60n -200 m, preferably 80 gm - 180 pm, more preferably 100 gm - 160 m. When the thickness is less than 60 m, sufficient adhesive force may be difficult to be secured during the adhesion period, and a thickness exceeding 200 gm is unpreferable for appropriate production and the like.
The adhesive material and adhesive preparation of the present invention can be produced by, for example, dissolving two kinds of synthetic rubbers having different flowability, a tackifier, an organic liquid, other additive as an optional component and a desired percutaneously absorbable drug in a suitable solvent such as toluene etc., applying the obtained adhesive solution to a liner (e.g., polyethylene terephthalate film subjected to a peel treatment with silicone etc.), drying the liner to form an adhesive layer, and laminating a support on the adhesive layer. Alternatively, they can be produced by, for example, directly applying the above-mentioned adhesive solution to a support and drying the support to form an adhesive layer.
A drug to be the active ingredient that can be contained in the adhesive preparation of the present invention is not particularly limited, and can be selected freely according to the treatment object. For example, percutaneously absorbable drugs of various kinds such as corticosteroids, analgesic/antiphlogistic, sedative hypnotic, tranquilizer, antihypertensive agent, hypotensive diuretic, antibiotic, anaesthetic, antibacterial agent, antifungal agent, vitamin, coronary vasodilator, antihistaminic agent, antitussive, sex hormone agent, antidepressant, cerebral circulation improver, antiemetic, antitumor agent, living organism pharmaceutical agent and the like, which do not dwell on the skin surface but penetrate subcutaneously or into the blood to exert a local effect or a systemic effect can be used . These drugs may be used in combination of two or more kinds thereof as necessary.
From the aspects of uniform dispersion in the above-mentioned adhesive layer and percutaneous absorbability, liposoluble drugs (dissolved amount 0.4 g or below/water 100 ml, ambient temperature) from among these drugs are particularly preferable. It is needless to say that not only percutaneously absorbable drugs but drugs that directly act on the skin wound etc. can be contained.
While the content of these percutaneously absorbable drugs can be appropriately determined according to the kind of drug and administration object, it is generally within the range of about 1-40 wt%, preferably 3-30 wt%, in an adhesive.
When the content is less than 1 wt%, release of an amount effective for the treatment or prophylaxis sometimes cannot be expected, and a content exceeding 40 wt% is economically disadvantageous because the increased amount does not lead to an increased effect and the adhesion to the skin surface may become inferior. In the present invention, the above-mentioned drugs do not need to be completely dissolved in an adhesive.
They may be contained in an amount exceeding the solubility in the adhesive to contain undissolved drug as well. In this case, however, the undissolved drug needs to be uniformly dispersed in a percutaneously absorbable adhesive preparation to prevent inconsistent content of the drug.
It is needless to say that a drug may be contained in an amount exceeding the above-mentioned range of drug content for the purpose of affording long-term sustained releaseability, increasing the amount of release by increasing the content per unit area, miniaturizing the preparation in an attempt to reduce skin irritation and the like.
The form of the adhesive material and adhesive preparation of the present invention is not particularly limited and, for example, a tape, a sheet and the like are mentioned.
While the size of the adhesive material and adhesive preparation of the present invention is not particularly limited, and varies depending on the adhesion site, the kind of drug to be contained, and age, body weight, condition etc.
of patient, it is generally about 10-100 cm2.
It is preferable to seal the adhesive material and adhesive preparation of the present invention until before use for preservation, transportation and the like. The packaging method includes, for example, superimposing one sheet or several sheets of the adhesive material and the adhesive preparation, packing them with a packaging material, and heat-sealing the part surrounding them. The packaging material is not particularly limited and may be, for example, a sheet or a film. From the aspects of easy packaging and air tightness, heat-sealable ones are preferable. Specific examples of suitable packaging materials include those using a plastic sheet having heat sealability, such as polyethylene, Surlyn (registered trademark), ethylene-vinyl acetate copolymer, ethylene-vinyl alcohol copolymer, polyacrylonitrile copolymer, polyvinyl alcohol copolymer and the like. Particularly, a laminate of a gas impermeable film such as polyester film, metal foil and the like is preferably used to prevent volatilization, scattering and the like of a percutaneously absorbable drug contained in the adhesive preparation. As the packaging material, one having a thickness of generally 10 Pm -200 pm is used.
Particularly, for an adhesive preparation containing a drug to be the active ingredient, the above-mentioned packaging material comprising a polyacrylonitrile copolymer having high barrier property in the innermost layer is more preferable. Moreover, out of the fear of degradation of handling property (e.g., easy taking out from a package) caused by the bleeding of the adhesive component due to the special adhesive property of the present invention, some design may be preferably employed, which is exemplified by a peel treatment or an emboss processing of the packaging material, a dry etching processing to somewhat enlarge the below-mentioned liner part than the preparation, a package formed by blister molding to reduce the contact area and the like.
The adhesive material and adhesive preparation of the present invention preferably have a release liner laminated thereon to protect the adhesive surface of an adhesive layer until use. The release liner is not particularly limited as long as it can be subjected to a peel treatment and certainly has a sufficient peelability. Examples thereof include films of polyester, polyvinyl chloride, polyvinylidene chloride, polyethylene terephthalate and the like, paper such as quality paper, glassine and the like, a laminate film of quality paper, glassine etc. with polyolefin, and the like, which have been subjected to a peel treatment comprising applying silicone resin, fluororesin and the like to the surface to be in contact with the adhesive layer. The thickness of the release liner is generally 10-200 m, preferably 25-100 m.
The release liner to be used for the adhesive preparation containing a drug is preferably made from a polyester (preferably, polyethylene terephthalate) resin, from the aspects of barrier property and cost. Moreover, the thickness is more preferably about 25-100 m.
The adhesive material and adhesive preparation of the present invention can be used by taking out by tearing the above-mentioned package immediately before use, removing the release liner, and adhering the exposed adhesive surface to the skin surface.
The adhesive material and adhesive preparation of the present invention can be easily peeled off from the skin surface without a pain or physical irritation after a desired period of 1 to 3 days previously determined based on the kind of drug.
In the case of adhesion for not less than 4 days, irritation etc. caused by being sealed and closed may not be dealt with, and sufficient adhesion property may not be necessarily maintained. Thus, the adhesion period in the present invention is preferably up to 3 days.
Examples The present invention is explained in detail in the following by referring to Examples, which are not to be construed as limitative. In the following, "part" and "%"
mean "parts by weight" and "wt%", respectively.
Examples 1 - 12, Comparative Examples 1 - 5 Each composition of Table 1-4 was dissolved in toluene to give a coating solution having a solute concentration of 35%. This solution was applied to a polyethylene terephthalate (PET) liner after a silicone peel treatment, such that the thickness of the coating after drying became 120 pm. This was dried in a hot-air circulation oven at 70 C for 2 min, 80 C for 2 min and 95 C for 3 min to give an adhesive layer. A non-woven fabric surface of a support made of a 2 pin thick PET film and a PET non-woven fabric (12 g/m2) adhered to each other with a polyester adhesive was laminated on the adhesive layer. This laminate was aged at room temperature for 2 days to give adhesive sheets of Examples 1-12 and Comparative Examples 1-5 of the present invention.
For measurement of the apparent viscosity, a sample free of lamination of the above-mentioned support, and having only an adhesive layer was recovered.
In the following Tables 1-4, each symbol means the following.
A: first synthetic rubber 2-methylpropene polymer B: second synthetic rubber 2-methylpropene polymer T1: tackifier 1,2-dimethylethylene polymer having a kinematic viscosity at 40 C of 600 mm 2/s T2: tackifier alicyclic saturated hydrocarbon resin having a softening point of 100 C
Jo: Staudinger-Index IPM: isopropyl myristate ISO: isostearyl alcohol Table 1 Composition of 3 day adhesive material A B tackifier additive Ex. T1 T2 IPM ISO
Mixing Mixing mixing mixing addi- addi-No. Jo ratio Jo ratio ratio ratio tion tion (%) (%) 5 Table 2 Composition of 2 day adhesive material Ex. A B Tackifier Additive No. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition ratio ratio (%) Table 3 Composition of 1 day adhesive material Ex. A B tackifier additive No. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition ratio ratio (%) Table 4 Composition of Comparative Example Com. A B tackifier additive Ex. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition No. ratio ratio (%) The physical property was measured by the following 10 method.
<measurement of Staudinger-Index>
The Staudinger-Index Jo (cm3/g) was measured according to ASTM D445, IS03104 under the following conditions.
viscosimeter: Ubbelohde Capillary 1 measurement temperature: 20 C
sample concentration J0<150:0.01 g/cm3 isooctane 150<J0<400:0.002 g/cm3 isooctane 400<J0:0.001 g/cm3 isooctane Jo=r)SP/c (1+0. 311 ) cm3/g (Schulz-Blaschke) Tlgp=t/to-1 t=flow time of solution (Hagenbach-couette correction) to=flow time of solvent (Hagenbach-couette correction) c=concentration of solution <measurement of kinematic viscosity>
Measured according to JIS K2283 and IS03104.
<measurement of softening point>
Measured according to pharmaceutical product additive standard (109992).
Experimental Example 1 (measurement of apparent viscosity measurement of adhesive force) The adhesive materials of Examples 1 - 12 and Comparative Examples 1 - 5 were measured for apparent viscosity and adhesive force according to the following methods. The results are shown in Table 5.
<measurement of apparent viscosity>
The aforementioned samples were subjected to the measurement under the following conditions using a flow tester CFT-500C (manufactured by Shimadzu Corporation) according to JIS K7210 and the values were used for the calculation by the following formulas. The sample density used was 1.0 g/cm2.
[measurement conditions]
sample temperature: 30 C
cylinder pressure: 30.0 kgf/cm2 die used: L:10.00 mm, D:1.00 mm preheating time: 300 s apparent shear stress: 7.36x105 dyn/cm2 Measurement start position S1: 3 mm Measurement end position S2: 7 mm [calculation equations]
Q=A = SZ-S1 (cm3/s) 1 0 0't y= 1 03 (s-1) nD3 PD
(P a) r nD4P
X 1 0-3 (P a= s) Each symbol in the equations shows the following.
Q: flow rate y: apparent shear velocity c: apparent shear stress r): apparent viscosity A: piston cross-section area (cm2) S1: measurement start position (mm) S2: measurement end position (mm) At: lapse of time for a piston to reach measurement end position from the measurement start position D: die bore diameter (mm) P: test pressure (Pa) L: die length (mm) <measurement of adhesive force>
A belt-like sample cut out in width 12 mm, length 200 mm was adhered to a BakeliteTmplate, allowed to closely adhere by one reciprocation of a roller (load 850 g), left standing at 23 C for 20 min, peeled off in a 1800 direction at 300 mm/min under 23 C, 60% RH conditions with a tension tester, and the peelability then was measured.
Table 5 Adhesive force and apparent viscosity Adhesive force Apparent viscosity Sample (N/12 mm) (Pa.s) Example 1 5.8 1.04x104 Example 2 7.5 0.59x104 Example 3 6.3 1.58x104 Example 4 6.5 1.32x104 Example 5 5.3 1.40x104 Example 6 5.5 2.41x104 Example 7 4.9 3.10x104 Example 8 6.2 5.04x104 Example 9 4.8 5.72x104 Example 10 4.4 8.51x104 Example 11 4.0 9.21x104 Example 12 5.5 6.65x104 Com. Example 1 2.6 17.4x104 Com. Example 2 10.4 0.14x104 Com. Example 3 4.5 12.6x104 Com. Example 4 5.4 0.08x104 Com. Example 5 7.1 0.18x104 Experimental Example 2 <human adhesion test>
The adhesive materials of Examples 1 - 12 and Comparative Examples 1 - 5 were prepared in length 10 cm and adhered to the inner side of the antebrachial region of volunteers (n=3). The peelability was measured at 2 hr after adhesion, 1 day after adhesion, 2 days after adhesion and 3 days after adhesion under the same conditions as in the adhesive force measurement in the aforementioned Experimental Example 1. The direction of peeling off was the 90 direction.
In addition, the presence of pain upon peeling off was also confirmed. The result of the peelability was an average value and the result of the presence of pain followed the opinion of the majority. The results are shown in Table 6.
In Table 6, in the column of pain upon peeling off, 0 means "no pain", Q means "a little pain", x means "considerable pain", "note 1" means "non-peelable due to cohesive failure", "note 2" means "not measureable due to falling off of the sample from the adhesion site", "note 3" means "not measured due to destruction (relocation) of sample by severe cohesive failure".
Table 6 Adhesion test Sample 2 hr later 1 day later 2 days later 3 days later Peel- Pain Peel- Pain Peel- Pain Peel- Pain abi- upon abi- upon abi- upon abi- upon lity peel- lity peel- lity peel- lity peel-(N/12 ing (N/12 ing (N/12 ing (N/12 ing mm) mm) mm) mm) Ex.l 14.8 x 5.18 A 2.36 0 1.18 0 note Ex.2 15.2 x 3.95 1.98 0 1.35 0 note Ex.3 13.6 x 4.44 Q 2.51 0 1.25 0 note Ex.4 12.9 x 3.02 A 2.27 0 1.10 0 note Ex.5 14.0 x 3.21 A 1.75 0 1.69 0 note Ex.6 14.8 x 2.92 A 1.66 O
note Ex.7 13.1 x 3.11 A 1.95 O
note Ex.8 12.6 x 5.01 A 1.35 O
note Ex.9 12.9 x 3.44 A 2.26 0 note Ex.10 11.1 x 1.63 0 note Ex. 11 12.6 X 1.51 0 note Ex. 12 12.9 X 1.70 0 note Com. -Ex. 1 3.48 A - note Com. X -8.84 note -Ex. 2 1 note Com. -Ex. 3 6.19 A - note Com. X
9.96 note -Ex. 4 1 note Com. X -7.52 note Ex.5 1 note Experimental Example 3 An adhesive preparation comprising the adhesive material of the above-mentioned Example 3, which has an adhesive layer containing 5% isosorbide dinitrate (ISDN) was prepared and subjected to an in vitro permeability test using the skin removed from a mouse. As a result, percutaneous absorption of ISDN was confirmed.
This application is based on patent application Nos.
235646/2004 and 215433/2005 filed in Japan.
According to another aspect of the present invention, there is provided an adhesive material comprising a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 300C
of 0.2x104 to 10x104Pa=s and comprises two kinds of synthetic rubbers having different flowability, wherein the synthetic rubber is a branched aliphatic hydrocarbon, and the proportion of the two kinds of synthetic rubbers relative to the total weight of the adhesive layer is 50-100%.
EFFECT OF THE INVENTION
The adhesive material of the present invention has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, and that allows easy peeling off from the skin surface without a pain or physical irritation after a certain, desired time period.
4a The adhesive preparation of the present invention has suitable adhesiveness that does not allow easy peeling off thereof for a certain time period after the adhesion to the skin surface, that does not cause skin irritation, can maintain fine absorbability of a percutaneously absorbable drug, which is an active ingredient, and can be easily peeled off from the skin surface without a pain or physical irritation after a certain, desired time period. Particularly, the adhesive material of the present invention can be easily peeled off after a desired period of 1 to 3 days by changing the mixing ratio of two kinds of synthetic rubbers having different flowability and tackifier to be added to the adhesive layer. Similarly, the adhesive preparation of the present invention is useful in that it can be peeled off easily after a desired period of 1 to 3 days according to the kind of the drug therein, which is an active ingredient.
In addition, an adhesive preparation obtained by adding 5% isosorbide dinitrate (ISDN) to the adhesive material of the present invention (Example 3 below) was subjected to an in vitro permeability test using a skin removed from a mouse, and the percutaneous absorbability of ISDN was confirmed. Thus, the adhesive preparation of the present invention is useful as a percutaneously absorbable adhesive preparation for continuous administration of a drug into the body.
BEST MODE FOR CARRYING OUT THE INVENTION
The adhesive material of the present invention is characterized in that an adhesive layer is laminated on one surface of a support, and the adhesive layer contains two kinds of synthetic rubbers having different flowability and has an apparent viscosity at 30 C of 0.2x104-10x104Pa=s.
Due to the above-mentioned constitution, the adhesive material has sufficient adhesiveness that does not allow easy peeling off at least in the initial stage of adhesion, maintains suitable adhesiveness, and permits peeling off with a force free of a pain or physical irritation after use.
While the support of the present invention is not particularly limited, those substantially impermeable to drug and the like, namely, those free of a decrease in the content due to the loss of a percutaneously absorbable drug, additives and the like from the adhesive layer through a support are preferable. As the support, for example, single films of polyester, nylon, saran (registered trademark), polyethylene, polypropylene, polyvinyl chloride, ethylene-ethyl acrylate copolymer, polytetrafluoroethylene, Surlyn (registered trademark), metal foil and the like, lamination films of these and the like can be used. Of these, the support is preferably a lamination film of a non-porous plastic film made from the above-mentioned material and a porous film, so as to improve the adhesive force (anchor property) between the support and an adhesive layer. In this case, the adhesive layer is preferably formed on the porous film side.
As such porous film, one capable of improving the anchor property with the adhesive layer can be employed.
Specifically, paper, woven fabric, non-woven fabric, knitted fabric, mechanically perforated sheet and the like can be mentioned. Of these, from the aspects of handling property and the like, paper, woven fabric and non-woven fabric are particularly preferable. A porous film having a thickness of 10-200 pm is employed from the aspects of improved anchor property, flexibility of adhesive material and adhesive preparation as a whole, and adhesion operability and the like.
In the case of a thin preparation such as a plaster type preparation and a pressure-sensitive adhesive tape type preparation, one having a thickness of 10-100 m is employed.
When a woven fabric or a non-woven fabric is used as the porous film, the fabric weight is preferably set to 5-30 g/m2, more preferably 6-15 g/m2. In the present invention, the most preferable support is a lamination film of a polyester film (preferably polyethylene terephthalate film) having a thickness of 1.5-6 pm and a non-woven polyester (preferably polyethylene terephthalate) fabric having a fabric weight of 6-12 g/m2.
The adhesive layer in the present invention comprises two kinds of synthetic rubbers having different flowability.
In the present invention, "having different flowability"
means difference in viscoelasticity due to different molecular weights and crosslinking densities, and the difference appears in, for example, glass transition temperature and kinematic viscosity. In general, the flowability can be expressed by a Staudinger-Index and the like.
In the present invention, the Staudinger-Index is measured according to ASTM D445, IS03104.
In the present specification, one of the two kinds of synthetic rubbers having different flowability is also referred to as the first synthetic rubber, and the other synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber is also referred to as the second synthetic rubber.
The apparent viscosity at 30 C of the adhesive layer in the present invention is 0.2x104 to 1Ox104Pa-s, preferably 0.5x104 to 9.5x104Pa-s. When the apparent viscosity at 30 C is less than 0.2x104Pa-s, cohesive failure markedly occurs irrespective of the duration of adhesion, and when it exceeds 1Ox104Pa-s, the adhesive force becomes insufficient and adhesiveness becomes poor.
The apparent viscosity in the present invention is obtained by measurement the following conditions according to JIS K7210 and using a flow tester CFT-500C (manufactured by Shimadzu Corporation), and calculation by the following calculation formulas.
[Measurement conditions]
Cylinder pressure: 30.0 kgf/cm2 Die used: L: 10.00 mm, D: 1.00 mm Preheating time: 300s Apparent shear stress: 7.36x105 dyn/cm2 Measurement start position S1: 3 mm Measurement end position S2: 7 mm Q=A = S2_S1 (cm3/s) 1 0 A t y= 1 03 (s-1) iD3 PD
(P a) T 7rD4P
n = X 1 0-3 (P a s) y 1 2 8 L Q
wherein each symbol shows the following:
Q: flow rate y: apparent shear velocity T: apparent shear stress ,n: apparent viscosity A: piston cross-section area (cm2) S1: measurement start position (mm) S2: measurement end position (mm) At: lapse of time for a piston to reach measurement end position from the measurement start position D: die bore diameter (mm) P: test pressure (Pa) L : die length (mm) As the synthetic rubber to be used in the present invention, for example, polydimethyl siloxane resin, butyl rubber, ethylene-vinylacetate copolymer, ethylene-ethylacrylate copolymer, polyalkylvinylether (e.g., polypropylvinylether, polyisopropylvinylether, polybutylvinylether etc.), 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, ethylethylene-1,2-dimethylethylene copolymer, polyisoprene, polybutadiene and the like can be mentioned, with preference given to 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, and ethylethylene-1,2-dimethylethylene copolymer, from the aspects of cost, handleability and the like.
As the synthetic rubber to be used in the present invention, a branched aliphatic hydrocarbon is particularly preferable. As the branched aliphatic hydrocarbon, for example, polymers and copolymers obtained from monomers such as 2-methylpropene, ethylethylene, 1,2-dimethylethylene and the like can be mentioned. Specifically, 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer, ethylethylene-l,2-dimethylethylene copolymer and the like can be mentioned.
In the present invention, two kinds of synthetic rubbers having different flowability are not particularly limited, but the first synthetic rubber is preferably a branched aliphatic hydrocarbon having a Staudinger-Index of 170-300 cm3/g, preferably 180-290 cm3/g, and the second synthetic rubber is preferably a branched aliphatic hydrocarbon having a Staudinger-Index of 30-60 cm3/g, preferably 35-55 cm3/g. In this case, when the Staudinger-Index of the first synthetic rubber is less than 170 cm3/g, the cohesion tends to become insufficient and when it exceeds 300 cm3/g, the tack of an adhesive tends to become low. When the Staudinger-Index of the second synthetic rubber is less than 30 cm3/g, the adhesive shows greater stickiness, which sometimes exerts an adverse influence on peeling in a desired number of days, and when it exceeds 60 cm3/g, the apparent viscosity of an adhesive becomes higher than the predetermined range, which may in turn result in a failure to adhere for the desired number of days.
As the branched aliphatic hydrocarbon when the first synthetic rubber is "a branched aliphatic hydrocarbon having a Staudinger-Index of 170-300 cm3/g (preferably 180-290 cm3/g)", 2-methylpropene polymer is preferable.
As the branched aliphatic hydrocarbon when the second synthetic rubber is "a branched aliphatic hydrocarbon having a Staudinger-Index of 30-60 cm3/g (preferably 35-55 cm3/g)", 2-methylpropene polymer, ethylethylene polymer, 1,2-dimethylethylene polymer and ethylethylene-1,2-dimethylethylene copolymer are preferable.
The proportion of the two kinds of synthetic rubbers having different flowability relative to the total weight of the adhesive layer is preferably 50-100%, more preferably 60-100%, in the total weight. The proportion of the first synthetic rubber of the two kinds of synthetic rubbers having different flowability relative to the whole weight of the adhesive layer is preferably 10-45%, more preferably 15-40%.
The proportion of the second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber, relative to the whole weight of the adhesive layer is preferably 30-85%, more preferably 35-80%. When the adhesive layer contains a drug, the above-mentioned proportion does not include the amount of the drug.
The adhesive layer in the present invention may further contain a tackifier. By the addition of a tackifier, the adhesion period from the start of the adhesion to the skin surface until the layer comes to have peelability permitting easy peeling off can be extended. In addition, by setting the mixing ratio of the two kinds of synthetic rubbers having different flowability and a tackifier to the one exemplified below, an adhesive preparation for a desired period of adhesion suitable for the kind of the drug can be prepared.
The tackifier to be used for the present invention may be appropriately selected from those known in the field of adhesive preparations. As the tackifier, for example, polybutenes, rosin resin, terpene resin, petroleum resin, chroman resin and the like can be mentioned. From the aspect of compatibility, (i) ethylethylene polymer, 1,2-dimethylethylene polymer and ethylethylene-l,2-dimethylethylene copolymer, each having a kinematic viscosity at 40 C of 200-4000 mm 2/s, preferably 500-700 mm2/s; and (ii) an alicyclic saturated hydrocarbon resin having a softening point of 70-125 C, preferably 90-115 C, are preferable. When the kinematic viscosity of the above-mentioned (i) is less than 200 mm2/s, the skin surface may become sticky after peeling off or the adhesive may bleed, and when it exceeds 4000 mm 2/s, a desired tack may not be obtained.
When the softening point of the above-mentioned (ii) is less than 70 C, the skin surface may become sticky after peeling off, the adhesive may bleed, or thermal stability may be degraded, and when it exceeds 125 C, compatibility may be degraded.
As the alicyclic saturated hydrocarbon resin having a softening point of 70-125 C, preferably 90-115 C, for example, a thermoplastic hydrogenation resin having an alicyclic structure formed by adding hydrogen to hydrocarbon resin obtained by polymerization of aromatic hydrocarbon (C9-C12) containing styrene, a-methylstyrene, vinyltoluene, indene, methylindene and the like, and the like can be mentioned.
The tackifier may be used in a combination of one or more kinds thereof.
The kinematic viscosity in the present invention is measured according to JIS K2283 and IS03104.
The softening point in the present invention is measured according to pharmaceutical product additive standard (109992).
The proportion of the tackifier relative to the total weight of the adhesive layer is preferably 0-40%, more preferably 0-30%, in the total weight. When a drug is contained, however, the above-mentioned proportion does not include the weight of the drug.
The adhesive layer in the present invention may further contain an organic liquid compatible with the above-mentioned two kinds of synthetic rubbers having different flowability, and the above-mentioned tackifier.
The organic liquid to be used in the present invention is not particularly limited as long as it is compatible with the above-mentioned two kinds of synthetic rubbers having different flowability, and the above-mentioned tackifier, and as long as it does not lose adhesive property. When an adhesive preparation containing a drug is produced, however, the organic liquid preferably dissolves the drug, and has an absorption promoting action to improve percutaneous absorbability of the contained drug. As the organic liquid, for example, higher alcohols such as oleyl alcohol, isostearyl alcohol, octyldodecanol and the like, oils and fats such as olive oil, castor oil, squalene, lanolin and the like, organic solvents such as ethyl acetate, ethyl alcohol, dimethyldecylsulfoxide, methyloctylsulfoxide, dimethylsulfoxide, dimethylformamide, dimethylacetamide, dodecylpyrrolidone, isosorbitol and the like, plasticizer liquid surfactants such as phthalate, diethyl sebacate, triethyl citriate, tributyl acetyl citrate and the like, liquid paraffin and the like hydrocarbons, ethoxylated stearyl alcohol, glycerine fatty acid ester, isopropyl myristate, isotridecyl myristate, ethyl laurate, N-methylpyrrolidone, ethyl oleate, oleic acid, diisopropyl adipate, isopropyl palmitate, 1,3-butanediol and the like can be mentioned. These organic liquids may be used in combination of one or more kinds thereof.
Of these organic liquids, preferred are fatty acid ester and glycerine fatty acid ester (particularly fatty acid monoglyceride). While these fatty acid esters and glycerine fatty acid esters are preferable as long as they plasticize an adhesive, a fatty acid having an unnecessarily large or small number of carbons may degrade compatibility with the aforementioned synthetic rubber and the like, or may be volatilized in a heating step for producing a preparation. In addition, an organic liquid made of a fatty acid having a double bond in a molecule may give rise to a problem in the preservation stability due to oxidative degradation and the like. Moreover, when an adhesive preparation is produced, a high content of a percutaneously absorbable drug per unit area leads to the precipitation of the drug above the saturation solubility in the preparation. Depending on the kind of fatty acid ester and glycerine fatty acid ester to be added, the crystal precipitation of the drug may be inhibited or precipitation may be delayed, which in turn may degrade the appearance of the obtained preparation or may adversely affect the preservation stability.
As the fatty acid ester to be used, therefore, a fatty acid ester comprising a higher fatty acid preferably having 12 to 16, more preferably 12-14, carbon atoms and a lower monovalent alcohol having 1 to 4 carbon atoms is employed. As such higher fatty acid, preferred are lauric acid (C12), myristic acid (C14) and palmitic acid (C16), and myristic acid is particularly preferable. As the lower monovalent alcohol, methyl alcohol, ethyl alcohol, propyl alcohol and butyl alcohol can be mentioned, which may be a straight chain alcohol or a branched alcohol. Desirably, isopropyl alcohol is used. Therefore, most preferable fatty acid ester is isopropyl myristate.
As the glycerine fatty acid ester, glyceride with higher fatty acid having 8 to 10 carbon atoms is preferable. As such higher fatty acid, preferred are caprylic acid (octanoic acid, C8), pelargonic acid (nonanoic acid, C9) and capric acid (decanoic acid, C10), and particularly preferred are caprylic monoglyceride, caprylic diglyceride, caprylic triglyceride and caprilyc capric triglyceride using caprylic acid.
When a higher alcohol is used as an organic liquid, for example, a saturated or unsaturated branched long-chain alcohol having 16 to 22, preferably 18-20, carbon atoms, such as isostearyl alcohol, octyldodecanol and the like are more preferable.
An embodiment wherein the organic liquid is isopropyl myristate and a branched long-chain alcohol is optionally contained as an organic liquid is particularly preferable. In this case, the mixing ratio of isopropyl myristate and a branched long-chain alcohol is preferably 1:0-4, more preferably 1:0-3, by weight.
When the mixing ratio of the branched long-chain alcohol relative to isopropyl myristate exceeds 4 by weight, the adhesiveness during perspiration may become lower and the preparation may come off during application.
The proportion of the organic liquid relative to the total weight of the adhesive layer is preferably not more than 20% in the total weight, so as to maintain special adhesive property of the present invention.
The adhesive layer may contain, as optional components, other additives (e.g., polymers such as polyvinylpyrrolidone, aminoalkyl methacrylate copolymer, methacrylic acid copolymer and the like, esters such as sorbitan fatty acid ester, propyleneglycol fatty acid ester and the like, inorganic compounds such as magnesium aluminum silicate and the like, other inorganic or organic fillers etc.), as long as the effect of the present invention is not inhibited. The proportion of other additives as optional components is preferably not more than 15% of the total weight of the adhesive layer.
In the present invention, by setting a particular mixing ratio of two kinds of synthetic rubbers having different flowability and a tackifier, an adhesive material permitting easy peeling off in a desired period of 1 to 3 days can be prepared. Particularly, the adhesive preparation of the present invention is useful because it can be easily peeled off in a desired period of 1 to 3 days according to the kind of the drug, which is an active ingredient.
For 3 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:12-20:7-11, by weight.
For 2 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:12-20:2-6, by weight.
For 1 day adhesion, the mixing ratio of a first synthetic rubber of two kinds of synthetic rubbers having different flowability, a second synthetic rubber having a lower Staudinger-Index value than that of the first synthetic rubber and a tackifier is set to, for example, 10:25-45:0-2, by weight.
The thickness of the adhesive layer is generally 60n -200 m, preferably 80 gm - 180 pm, more preferably 100 gm - 160 m. When the thickness is less than 60 m, sufficient adhesive force may be difficult to be secured during the adhesion period, and a thickness exceeding 200 gm is unpreferable for appropriate production and the like.
The adhesive material and adhesive preparation of the present invention can be produced by, for example, dissolving two kinds of synthetic rubbers having different flowability, a tackifier, an organic liquid, other additive as an optional component and a desired percutaneously absorbable drug in a suitable solvent such as toluene etc., applying the obtained adhesive solution to a liner (e.g., polyethylene terephthalate film subjected to a peel treatment with silicone etc.), drying the liner to form an adhesive layer, and laminating a support on the adhesive layer. Alternatively, they can be produced by, for example, directly applying the above-mentioned adhesive solution to a support and drying the support to form an adhesive layer.
A drug to be the active ingredient that can be contained in the adhesive preparation of the present invention is not particularly limited, and can be selected freely according to the treatment object. For example, percutaneously absorbable drugs of various kinds such as corticosteroids, analgesic/antiphlogistic, sedative hypnotic, tranquilizer, antihypertensive agent, hypotensive diuretic, antibiotic, anaesthetic, antibacterial agent, antifungal agent, vitamin, coronary vasodilator, antihistaminic agent, antitussive, sex hormone agent, antidepressant, cerebral circulation improver, antiemetic, antitumor agent, living organism pharmaceutical agent and the like, which do not dwell on the skin surface but penetrate subcutaneously or into the blood to exert a local effect or a systemic effect can be used . These drugs may be used in combination of two or more kinds thereof as necessary.
From the aspects of uniform dispersion in the above-mentioned adhesive layer and percutaneous absorbability, liposoluble drugs (dissolved amount 0.4 g or below/water 100 ml, ambient temperature) from among these drugs are particularly preferable. It is needless to say that not only percutaneously absorbable drugs but drugs that directly act on the skin wound etc. can be contained.
While the content of these percutaneously absorbable drugs can be appropriately determined according to the kind of drug and administration object, it is generally within the range of about 1-40 wt%, preferably 3-30 wt%, in an adhesive.
When the content is less than 1 wt%, release of an amount effective for the treatment or prophylaxis sometimes cannot be expected, and a content exceeding 40 wt% is economically disadvantageous because the increased amount does not lead to an increased effect and the adhesion to the skin surface may become inferior. In the present invention, the above-mentioned drugs do not need to be completely dissolved in an adhesive.
They may be contained in an amount exceeding the solubility in the adhesive to contain undissolved drug as well. In this case, however, the undissolved drug needs to be uniformly dispersed in a percutaneously absorbable adhesive preparation to prevent inconsistent content of the drug.
It is needless to say that a drug may be contained in an amount exceeding the above-mentioned range of drug content for the purpose of affording long-term sustained releaseability, increasing the amount of release by increasing the content per unit area, miniaturizing the preparation in an attempt to reduce skin irritation and the like.
The form of the adhesive material and adhesive preparation of the present invention is not particularly limited and, for example, a tape, a sheet and the like are mentioned.
While the size of the adhesive material and adhesive preparation of the present invention is not particularly limited, and varies depending on the adhesion site, the kind of drug to be contained, and age, body weight, condition etc.
of patient, it is generally about 10-100 cm2.
It is preferable to seal the adhesive material and adhesive preparation of the present invention until before use for preservation, transportation and the like. The packaging method includes, for example, superimposing one sheet or several sheets of the adhesive material and the adhesive preparation, packing them with a packaging material, and heat-sealing the part surrounding them. The packaging material is not particularly limited and may be, for example, a sheet or a film. From the aspects of easy packaging and air tightness, heat-sealable ones are preferable. Specific examples of suitable packaging materials include those using a plastic sheet having heat sealability, such as polyethylene, Surlyn (registered trademark), ethylene-vinyl acetate copolymer, ethylene-vinyl alcohol copolymer, polyacrylonitrile copolymer, polyvinyl alcohol copolymer and the like. Particularly, a laminate of a gas impermeable film such as polyester film, metal foil and the like is preferably used to prevent volatilization, scattering and the like of a percutaneously absorbable drug contained in the adhesive preparation. As the packaging material, one having a thickness of generally 10 Pm -200 pm is used.
Particularly, for an adhesive preparation containing a drug to be the active ingredient, the above-mentioned packaging material comprising a polyacrylonitrile copolymer having high barrier property in the innermost layer is more preferable. Moreover, out of the fear of degradation of handling property (e.g., easy taking out from a package) caused by the bleeding of the adhesive component due to the special adhesive property of the present invention, some design may be preferably employed, which is exemplified by a peel treatment or an emboss processing of the packaging material, a dry etching processing to somewhat enlarge the below-mentioned liner part than the preparation, a package formed by blister molding to reduce the contact area and the like.
The adhesive material and adhesive preparation of the present invention preferably have a release liner laminated thereon to protect the adhesive surface of an adhesive layer until use. The release liner is not particularly limited as long as it can be subjected to a peel treatment and certainly has a sufficient peelability. Examples thereof include films of polyester, polyvinyl chloride, polyvinylidene chloride, polyethylene terephthalate and the like, paper such as quality paper, glassine and the like, a laminate film of quality paper, glassine etc. with polyolefin, and the like, which have been subjected to a peel treatment comprising applying silicone resin, fluororesin and the like to the surface to be in contact with the adhesive layer. The thickness of the release liner is generally 10-200 m, preferably 25-100 m.
The release liner to be used for the adhesive preparation containing a drug is preferably made from a polyester (preferably, polyethylene terephthalate) resin, from the aspects of barrier property and cost. Moreover, the thickness is more preferably about 25-100 m.
The adhesive material and adhesive preparation of the present invention can be used by taking out by tearing the above-mentioned package immediately before use, removing the release liner, and adhering the exposed adhesive surface to the skin surface.
The adhesive material and adhesive preparation of the present invention can be easily peeled off from the skin surface without a pain or physical irritation after a desired period of 1 to 3 days previously determined based on the kind of drug.
In the case of adhesion for not less than 4 days, irritation etc. caused by being sealed and closed may not be dealt with, and sufficient adhesion property may not be necessarily maintained. Thus, the adhesion period in the present invention is preferably up to 3 days.
Examples The present invention is explained in detail in the following by referring to Examples, which are not to be construed as limitative. In the following, "part" and "%"
mean "parts by weight" and "wt%", respectively.
Examples 1 - 12, Comparative Examples 1 - 5 Each composition of Table 1-4 was dissolved in toluene to give a coating solution having a solute concentration of 35%. This solution was applied to a polyethylene terephthalate (PET) liner after a silicone peel treatment, such that the thickness of the coating after drying became 120 pm. This was dried in a hot-air circulation oven at 70 C for 2 min, 80 C for 2 min and 95 C for 3 min to give an adhesive layer. A non-woven fabric surface of a support made of a 2 pin thick PET film and a PET non-woven fabric (12 g/m2) adhered to each other with a polyester adhesive was laminated on the adhesive layer. This laminate was aged at room temperature for 2 days to give adhesive sheets of Examples 1-12 and Comparative Examples 1-5 of the present invention.
For measurement of the apparent viscosity, a sample free of lamination of the above-mentioned support, and having only an adhesive layer was recovered.
In the following Tables 1-4, each symbol means the following.
A: first synthetic rubber 2-methylpropene polymer B: second synthetic rubber 2-methylpropene polymer T1: tackifier 1,2-dimethylethylene polymer having a kinematic viscosity at 40 C of 600 mm 2/s T2: tackifier alicyclic saturated hydrocarbon resin having a softening point of 100 C
Jo: Staudinger-Index IPM: isopropyl myristate ISO: isostearyl alcohol Table 1 Composition of 3 day adhesive material A B tackifier additive Ex. T1 T2 IPM ISO
Mixing Mixing mixing mixing addi- addi-No. Jo ratio Jo ratio ratio ratio tion tion (%) (%) 5 Table 2 Composition of 2 day adhesive material Ex. A B Tackifier Additive No. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition ratio ratio (%) Table 3 Composition of 1 day adhesive material Ex. A B tackifier additive No. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition ratio ratio (%) Table 4 Composition of Comparative Example Com. A B tackifier additive Ex. Jo Mixing Jo Mixing Ti T2 IPM
ratio ratio mixing mixing addition No. ratio ratio (%) The physical property was measured by the following 10 method.
<measurement of Staudinger-Index>
The Staudinger-Index Jo (cm3/g) was measured according to ASTM D445, IS03104 under the following conditions.
viscosimeter: Ubbelohde Capillary 1 measurement temperature: 20 C
sample concentration J0<150:0.01 g/cm3 isooctane 150<J0<400:0.002 g/cm3 isooctane 400<J0:0.001 g/cm3 isooctane Jo=r)SP/c (1+0. 311 ) cm3/g (Schulz-Blaschke) Tlgp=t/to-1 t=flow time of solution (Hagenbach-couette correction) to=flow time of solvent (Hagenbach-couette correction) c=concentration of solution <measurement of kinematic viscosity>
Measured according to JIS K2283 and IS03104.
<measurement of softening point>
Measured according to pharmaceutical product additive standard (109992).
Experimental Example 1 (measurement of apparent viscosity measurement of adhesive force) The adhesive materials of Examples 1 - 12 and Comparative Examples 1 - 5 were measured for apparent viscosity and adhesive force according to the following methods. The results are shown in Table 5.
<measurement of apparent viscosity>
The aforementioned samples were subjected to the measurement under the following conditions using a flow tester CFT-500C (manufactured by Shimadzu Corporation) according to JIS K7210 and the values were used for the calculation by the following formulas. The sample density used was 1.0 g/cm2.
[measurement conditions]
sample temperature: 30 C
cylinder pressure: 30.0 kgf/cm2 die used: L:10.00 mm, D:1.00 mm preheating time: 300 s apparent shear stress: 7.36x105 dyn/cm2 Measurement start position S1: 3 mm Measurement end position S2: 7 mm [calculation equations]
Q=A = SZ-S1 (cm3/s) 1 0 0't y= 1 03 (s-1) nD3 PD
(P a) r nD4P
X 1 0-3 (P a= s) Each symbol in the equations shows the following.
Q: flow rate y: apparent shear velocity c: apparent shear stress r): apparent viscosity A: piston cross-section area (cm2) S1: measurement start position (mm) S2: measurement end position (mm) At: lapse of time for a piston to reach measurement end position from the measurement start position D: die bore diameter (mm) P: test pressure (Pa) L: die length (mm) <measurement of adhesive force>
A belt-like sample cut out in width 12 mm, length 200 mm was adhered to a BakeliteTmplate, allowed to closely adhere by one reciprocation of a roller (load 850 g), left standing at 23 C for 20 min, peeled off in a 1800 direction at 300 mm/min under 23 C, 60% RH conditions with a tension tester, and the peelability then was measured.
Table 5 Adhesive force and apparent viscosity Adhesive force Apparent viscosity Sample (N/12 mm) (Pa.s) Example 1 5.8 1.04x104 Example 2 7.5 0.59x104 Example 3 6.3 1.58x104 Example 4 6.5 1.32x104 Example 5 5.3 1.40x104 Example 6 5.5 2.41x104 Example 7 4.9 3.10x104 Example 8 6.2 5.04x104 Example 9 4.8 5.72x104 Example 10 4.4 8.51x104 Example 11 4.0 9.21x104 Example 12 5.5 6.65x104 Com. Example 1 2.6 17.4x104 Com. Example 2 10.4 0.14x104 Com. Example 3 4.5 12.6x104 Com. Example 4 5.4 0.08x104 Com. Example 5 7.1 0.18x104 Experimental Example 2 <human adhesion test>
The adhesive materials of Examples 1 - 12 and Comparative Examples 1 - 5 were prepared in length 10 cm and adhered to the inner side of the antebrachial region of volunteers (n=3). The peelability was measured at 2 hr after adhesion, 1 day after adhesion, 2 days after adhesion and 3 days after adhesion under the same conditions as in the adhesive force measurement in the aforementioned Experimental Example 1. The direction of peeling off was the 90 direction.
In addition, the presence of pain upon peeling off was also confirmed. The result of the peelability was an average value and the result of the presence of pain followed the opinion of the majority. The results are shown in Table 6.
In Table 6, in the column of pain upon peeling off, 0 means "no pain", Q means "a little pain", x means "considerable pain", "note 1" means "non-peelable due to cohesive failure", "note 2" means "not measureable due to falling off of the sample from the adhesion site", "note 3" means "not measured due to destruction (relocation) of sample by severe cohesive failure".
Table 6 Adhesion test Sample 2 hr later 1 day later 2 days later 3 days later Peel- Pain Peel- Pain Peel- Pain Peel- Pain abi- upon abi- upon abi- upon abi- upon lity peel- lity peel- lity peel- lity peel-(N/12 ing (N/12 ing (N/12 ing (N/12 ing mm) mm) mm) mm) Ex.l 14.8 x 5.18 A 2.36 0 1.18 0 note Ex.2 15.2 x 3.95 1.98 0 1.35 0 note Ex.3 13.6 x 4.44 Q 2.51 0 1.25 0 note Ex.4 12.9 x 3.02 A 2.27 0 1.10 0 note Ex.5 14.0 x 3.21 A 1.75 0 1.69 0 note Ex.6 14.8 x 2.92 A 1.66 O
note Ex.7 13.1 x 3.11 A 1.95 O
note Ex.8 12.6 x 5.01 A 1.35 O
note Ex.9 12.9 x 3.44 A 2.26 0 note Ex.10 11.1 x 1.63 0 note Ex. 11 12.6 X 1.51 0 note Ex. 12 12.9 X 1.70 0 note Com. -Ex. 1 3.48 A - note Com. X -8.84 note -Ex. 2 1 note Com. -Ex. 3 6.19 A - note Com. X
9.96 note -Ex. 4 1 note Com. X -7.52 note Ex.5 1 note Experimental Example 3 An adhesive preparation comprising the adhesive material of the above-mentioned Example 3, which has an adhesive layer containing 5% isosorbide dinitrate (ISDN) was prepared and subjected to an in vitro permeability test using the skin removed from a mouse. As a result, percutaneous absorption of ISDN was confirmed.
This application is based on patent application Nos.
235646/2004 and 215433/2005 filed in Japan.
Claims (15)
1. An adhesive material comprising a support and an adhesive layer laminated on one surface of the support, wherein the adhesive layer has an apparent viscosity at 30°C of 0.2×10 4 to 10×10 4Pa.cndot.s and comprises two kinds of synthetic rubbers having different flowability, wherein the synthetic rubber is a branched aliphatic hydrocarbon, and the proportion of the two kinds of synthetic rubbers relative to the total weight of the adhesive layer is 50-100%.
2. The adhesive material of claim 1, wherein said adhesive layer may further comprise a tackifier.
3. The adhesive material of claim 2, wherein said adhesive layer further comprises an organic liquid compatible with said two kinds of synthetic rubbers and the tackifier.
4. The adhesive material of claim 3, wherein the organic liquid is contained in a proportion of not more than 20% of the total weight of said adhesive layer.
5. The adhesive material of claim 1 or 2, wherein the two kinds of synthetic rubbers comprise a first synthetic rubber, which has a Staudinger Index of 170-300 cm3/g, and a second synthetic rubber, which has a Staudinger Index of 30-60 cm3/g.
6. The adhesive material of claim 5, wherein the branched aliphatic hydrocarbon of the first synthetic rubber and/or the second synthetic rubber is a 2-methylpropene polymer.
7. The adhesive material of claim 2, wherein the tackifier is an ethylethylene polymer, a 1,2-dimethylethylene polymer or an ethylethylene-1,2-dimethylethylene copolymer having a kinematic viscosity at 40°C of 200-4000 mm2/s.
8. The adhesive material of claim 2, wherein the tackifier is an alicyclic saturated hydrocarbon resin having a softening point of 70-125°C.
9. The adhesive material of claim 2, wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a second synthetic rubber having a lower Staudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:12-20:7-11 by weight.
10. The adhesive material of claim 2, wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a second synthetic rubber having a lower Staudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:12-20:2-6 by weight.
11. The adhesive material of claim 2, wherein the two kinds of synthetic rubbers comprise a first synthetic rubber and a second synthetic rubber having a lower Saudinger Index than the first synthetic rubber, and a mixing ratio of the first synthetic rubber:the second synthetic rubber:tackifier is 10:25-45:0-2 by weight.
12. The adhesive material of claim 3 or 4, wherein the organic liquid is at least one member selected from isopropyl myristate and a branched alcohol having 16 to 22 carbon atoms.
13. The adhesive material of claim 12, wherein the organic liquid is isopropyl myristate, the organic liquid optionally further comprises a branched alcohol having 16 to 22 carbon atoms, and a mixing ratio of isopropyl myristate:branched alcohol having 16 to 22 carbon atoms is 1:0-4 by weight.
14. The adhesive material of claim 12 or 13, wherein the branched alcohol having 16 to 22 carbon atoms is at least one member selected from isostearyl alcohol and octyldodecanol.
15. An adhesive preparation comprising a percutaneously absorbable drug in the adhesive layer of the adhesive material of any one of claims 1 to 14.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004235646 | 2004-08-12 | ||
| JP235646/2004 | 2004-08-12 | ||
| JP215433/2005 | 2005-07-26 | ||
| JP2005215433A JP4824963B2 (en) | 2004-08-12 | 2005-07-26 | Patch and patch preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2514636A1 CA2514636A1 (en) | 2006-02-12 |
| CA2514636C true CA2514636C (en) | 2012-11-27 |
Family
ID=35169685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2514636A Active CA2514636C (en) | 2004-08-12 | 2005-08-04 | Adhesive material and adhesive preparation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8394404B2 (en) |
| EP (1) | EP1625846B1 (en) |
| JP (1) | JP4824963B2 (en) |
| KR (1) | KR101215247B1 (en) |
| CA (1) | CA2514636C (en) |
| RU (1) | RU2372075C2 (en) |
| TW (1) | TWI388346B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4745747B2 (en) * | 2004-08-12 | 2011-08-10 | 日東電工株式会社 | Fentanyl-containing patch preparation |
| JP5015562B2 (en) * | 2005-12-13 | 2012-08-29 | 日東電工株式会社 | Patch preparation |
| JP4392016B2 (en) * | 2006-11-22 | 2009-12-24 | 日東電工株式会社 | Patch preparation |
| JP5227041B2 (en) * | 2007-02-28 | 2013-07-03 | 日東電工株式会社 | Drug-containing patch preparation |
| JP5242950B2 (en) * | 2007-06-15 | 2013-07-24 | 日東電工株式会社 | Gel composition and use thereof |
| JP5097034B2 (en) * | 2007-07-20 | 2012-12-12 | 日東電工株式会社 | Patches and patch preparations |
| JP5860201B2 (en) * | 2010-02-12 | 2016-02-16 | 久光製薬株式会社 | Transdermal absorption preparation and method for producing the same |
| JP5698018B2 (en) | 2011-02-02 | 2015-04-08 | 日東電工株式会社 | Patches and patch preparations |
| KR101857316B1 (en) * | 2011-02-02 | 2018-05-11 | 닛토덴코 가부시키가이샤 | Patch and patch preparation |
| RU2470670C1 (en) * | 2011-10-25 | 2012-12-27 | Российская Федерация в лице Министерства промышленности и торговли Российской Федерации | Medical plaster-type fixer |
| CN113303172A (en) * | 2020-02-26 | 2021-08-27 | 施利宜 | Sealing film manufacturing process and planting container comprising same |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| GB8300074D0 (en) * | 1983-01-04 | 1983-02-09 | Du Pont Canada | Blends of polyethylene and polybutenes |
| US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| DE3682165D1 (en) * | 1985-11-08 | 1991-11-28 | Nitto Denko Corp | USE OF ADHESIVE PLASTERS FOR THE SKIN AND PERCUTANEOUS PREPARATIONS. |
| US4822802A (en) * | 1987-02-24 | 1989-04-18 | Alza Corporation | Method of fentanly administration for postoperative pain relief |
| US5405486A (en) * | 1988-03-04 | 1995-04-11 | Noven Pharmaceuticals, Inc. | Apparatus for forming a transdermal drug device |
| JP2681365B2 (en) * | 1988-04-11 | 1997-11-26 | 日東電工株式会社 | Percutaneous absorption preparation and its manufacturing method |
| JP2524190B2 (en) | 1988-05-11 | 1996-08-14 | 日東電工株式会社 | Adhesive tape formulation containing clonidine |
| US5175052A (en) * | 1988-05-11 | 1992-12-29 | Nitto Denko Corporation | Adhesive tape preparation of clonidine |
| CA2029172C (en) * | 1989-11-28 | 2002-04-02 | Eric Flam | Dressing including an indicator |
| US5204109A (en) * | 1989-12-28 | 1993-04-20 | Nitto Denko Corporation | Percutaneous gel preparation |
| JP3273430B2 (en) * | 1989-12-28 | 2002-04-08 | 日東電工株式会社 | Estrogen-containing gel preparation |
| US5298258A (en) * | 1989-12-28 | 1994-03-29 | Nitto Denko Corporation | Acrylic oily gel bioadhesive material and acrylic oily gel preparation |
| JP2970772B2 (en) | 1989-12-28 | 1999-11-02 | 日東電工株式会社 | Transdermal gel preparation |
| US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
| US5163616A (en) * | 1991-01-14 | 1992-11-17 | Block Drug Company, Inc. | Air freshener device with visual signal means |
| JPH0764114B2 (en) | 1991-12-26 | 1995-07-12 | 大蔵省印刷局長 | Magnetic printed matter |
| KR950702811A (en) | 1992-08-25 | 1995-08-23 | 더블유. 클레어리 게리 | Printed Transdermal Drug Delivery Device |
| JP3594963B2 (en) * | 1992-09-25 | 2004-12-02 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | A method of skin treatment with adhesiveness enhancing properties. |
| DE4333595A1 (en) | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermal therapeutic system for applying drugs to the skin |
| US5820878A (en) * | 1994-11-18 | 1998-10-13 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneously absorbable patch |
| JP3908795B2 (en) | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | Ketotifen-containing transdermal preparation |
| NZ311304A (en) * | 1995-06-07 | 1999-03-29 | Cygnus Therapeutic Systems | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| DE19527925C2 (en) * | 1995-07-29 | 1997-07-03 | Lohmann Therapie Syst Lts | Transdermal therapeutic system with a release agent-coated protective layer |
| JPH0999050A (en) * | 1995-10-05 | 1997-04-15 | Sekisui Chem Co Ltd | Patch material |
| TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
| US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| JPH10152434A (en) * | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | Percutaneous absorption type preparation |
| JPH10151185A (en) * | 1996-11-21 | 1998-06-09 | Nichiban Co Ltd | On-skin sticking adhesive tape |
| GB9714650D0 (en) * | 1997-07-11 | 1997-09-17 | Strakan Ltd | Block copolymer |
| US6420622B1 (en) * | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
| US5948433A (en) * | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
| AU2713199A (en) * | 1998-03-13 | 1999-10-11 | Coloplast A/S | A pressure sensitive adhesive composition |
| EP1002838A1 (en) | 1998-11-11 | 2000-05-24 | Lafarge Braas Roofing Accessories GmbH & Co. KG. | Filling paste for waterproof coatings |
| US6348210B1 (en) | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
| JP2000344697A (en) * | 1999-06-03 | 2000-12-12 | Nippon Fine Chem Co Ltd | Long-chain branched alcohol and cosmetic and external preparation produced by using the alcohol |
| JP2001029383A (en) * | 1999-07-21 | 2001-02-06 | Nitto Denko Corp | Medical patch and percutaneous absorption type patch pharmaceutical preparation |
| US20030109819A1 (en) * | 1999-12-15 | 2003-06-12 | Kiyomi Tsuruda | Adhesive preparations |
| US20020004065A1 (en) * | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
| JP4573383B2 (en) * | 2000-01-24 | 2010-11-04 | 日本精化株式会社 | Cosmetic oil and cosmetics and external preparations using the same |
| US6592888B1 (en) * | 2000-05-31 | 2003-07-15 | Jentec, Inc. | Composition for wound dressings safely using metallic compounds to produce anti-microbial properties |
| JP5021124B2 (en) * | 2001-08-29 | 2012-09-05 | 日東電工株式会社 | Medical adhesive composition, medical adhesive tape and transdermal absorption tape formulation using the same |
| JP2003137773A (en) | 2001-10-31 | 2003-05-14 | Hisamitsu Pharmaceut Co Inc | Patch having laminated support |
| JP3826057B2 (en) * | 2001-11-27 | 2006-09-27 | 日本精化株式会社 | Lanolin-like composition and cosmetics and skin external preparations containing the same |
| TWI296531B (en) | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
| JP4745747B2 (en) * | 2004-08-12 | 2011-08-10 | 日東電工株式会社 | Fentanyl-containing patch preparation |
| JP2008525235A (en) * | 2004-12-23 | 2008-07-17 | エーブリー デニソン コーポレイション | Heat-shrinkable film and articles enclosed in the film |
-
2005
- 2005-07-26 JP JP2005215433A patent/JP4824963B2/en active Active
- 2005-08-01 TW TW094126013A patent/TWI388346B/en active
- 2005-08-02 EP EP05107128.0A patent/EP1625846B1/en active Active
- 2005-08-04 RU RU2005124859/15A patent/RU2372075C2/en active
- 2005-08-04 CA CA2514636A patent/CA2514636C/en active Active
- 2005-08-04 US US11/196,936 patent/US8394404B2/en active Active
- 2005-08-05 KR KR1020050071781A patent/KR101215247B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1625846A3 (en) | 2006-07-05 |
| EP1625846A2 (en) | 2006-02-15 |
| KR20060050268A (en) | 2006-05-19 |
| TWI388346B (en) | 2013-03-11 |
| JP2006075588A (en) | 2006-03-23 |
| JP4824963B2 (en) | 2011-11-30 |
| EP1625846B1 (en) | 2015-02-18 |
| TW200613013A (en) | 2006-05-01 |
| KR101215247B1 (en) | 2012-12-24 |
| RU2005124859A (en) | 2007-02-10 |
| US20060034901A1 (en) | 2006-02-16 |
| CA2514636A1 (en) | 2006-02-12 |
| RU2372075C2 (en) | 2009-11-10 |
| US8394404B2 (en) | 2013-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2514636C (en) | Adhesive material and adhesive preparation | |
| RU2396951C2 (en) | Adhesive pharmaceutical bisopropol-containing composition | |
| US8591939B2 (en) | Adhesive preparation containing fentanyl | |
| AU2011343363B2 (en) | Transdermal therapeutic system for administering an active substance | |
| JP5016309B2 (en) | Medical tape | |
| EP2110125B1 (en) | Transdermal drug administration device | |
| JP4145996B2 (en) | Acrylic adhesive tape and transdermal absorption preparation | |
| KR101942677B1 (en) | Adhesive plaster | |
| KR102090411B1 (en) | Patch | |
| JP2007016019A (en) | Percutaneously absorbable pharmaceutical preparation | |
| EP2570122B1 (en) | Composition for Enhancing Transdermal Absorption of A Drug and Patch Preparation | |
| EP2143445B1 (en) | Medicated patch | |
| JP2007031322A (en) | Plaster | |
| JPWO2019146614A1 (en) | Patch | |
| JP2001181591A (en) | Block copolymer adhesive and medical adhesive tape and percutaneous absorption pharmaceutical preparation using this and preparation method of block copolymer adhesive | |
| CN100563726C (en) | Adhesive material and adhesive formulation | |
| JP5085062B2 (en) | Transdermal patch | |
| JP5227041B2 (en) | Drug-containing patch preparation | |
| JP5281973B2 (en) | Bisoprolol-containing patch | |
| AU735450B2 (en) | Plasticizer and patch containing the same | |
| CA2790749A1 (en) | Manufacturing method of patch preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |